Apr 29, 2026, 14:26 by ASAM Weekly Editors

New Standards for Adolescent Substance Use Disorder Care

Apr 27, 2026, 10:40 by R. Corey Waller, MD, MS, FACEP, DFASAM

If we hope to improve our response to the addiction and overdose crisis, we must focus on when addiction commonly starts: adolescence. Addiction is a pediatric-onset illness, as ongoing neurodevelopment makes the adolescent brain particularly vulnerable to the effects of substances. In fact, 80% of adults with substance use disorder (SUD) begin using substances before the age of 18.1,2 Not only is the neurobiology of adolescents unique, but so are their social, educational, and mental and physical health needs.

Apr 22, 2026, 15:39 by ASAM Weekly Editors

A opioid receptor superagonist analgesic with minimal adverse effects

Apr 21, 2026, 11:24 by Sarah Shelson

Apr 20, 2026, 18:12 by Sarah Shelson

Apr 16, 2026, 13:50 by ASAM Weekly Editors

New ASAM Implementation Guide for Hospital and EDs

Apr 13, 2026, 19:31 by R. Corey Waller, MD, MS, FACEP, DFASAM

Patients with substance use disorder (SUD) have frequent touchpoints with general hospitals and emergency departments (EDs). Between 2014 and 2018, 11.9% of inpatient hospitalizations and 9.4% of ED visits were for patients with SUD. The toll of not treating SUD is enormous, with high rates of premature discharge, cost, and mortality after discharge.

Apr 8, 2026, 14:31 by Sarah Shelson

Apr 8, 2026, 10:28 by ASAM Weekly Editors

Do US Adults View Drug and Alcohol Addiction as a Health Condition?

Apr 1, 2026, 08:54 by ASAM Weekly Editors

Treating Opioid Use Disorder With Methadone in Pharmacies

Mar 30, 2026, 15:19 by Sarah Shelson

Mar 30, 2026, 09:00 by Sarah Shelson

Mar 27, 2026, 10:33 by Sarah Shelson

Mar 26, 2026, 15:32 by Sarah Shelson

Mar 26, 2026, 13:30 by Sarah Shelson

Mar 25, 2026, 11:23 by ASAM Weekly Editors

Cost-effectiveness of contingency management for methamphetamine use disorder: A model-based analysis

Mar 25, 2026, 08:00 by Sarah Shelson

Mar 20, 2026, 10:54 by Sarah Shelson

Mar 20, 2026, 10:39 by ASAM Weekly Editors

Glucagon-like peptide-1 receptor agonists and risk of substance use disorders

Mar 18, 2026, 16:50 by Sarah Shelson